What should I Know Regarding Pregnancy, Nursing and Administering Amikacin Liposomal-Neb.Accessr Suspension For Nebulization to Children or the Elderly?

If you are PREGNANT

  • FDB Only When Necessary: SYSTEMIC ABSORPTION IS LIKELY TO BE LOW AFTER ORAL INHALATION

If you are NURSING

  • No Known Risk: TRACE AMOUNTS EXCRETED, POOR ORAL ABSORPTION

If you are an adult over 60

  • management or monitoring precaution: General-No overall differences in safety and effectiveness have been observed between elderly subjects and younger subjects. Renal-Liposomal inhaled amikacin has not been studied in patients with renal impairment. Given the low systemic exposure to amikacin following administration, clinically relevant accumulation of amikacin is unlikely to occur in patients with renal impairment. However, renal function should be monitored in patients with known or suspected renal impairment.

Giving Amikacin Liposomal-Neb.Accessr Suspension For Nebulization to a child under 12

  • management or monitoring precaution: No pediatric safety and efficacy established.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.